Institute of Tropical Medicine, Universitätsklinikum Tübingen, Wilhelmstrasse 27, 72074, Tübingen, Germany.
Vietnamese-German Centre for Medical Research (VG-CARE), Hanoi, Vietnam.
Malar J. 2020 Dec 31;19(1):458. doi: 10.1186/s12936-020-03561-6.
While the World Health Organization (WHO) Southeast Asia region has the second highest incidence of malaria worldwide, malaria in Vietnam is focal to few provinces, where delayed parasite clearance to anti-malarial drugs is documented. This study aims to understand Plasmodium species distribution and the genetic diversity of msp1 and msp2 of parasite populations using molecular tools.
A total of 222 clinical isolates from individuals with uncomplicated malaria were subjected to Plasmodium species identification by nested real-time PCR. 166 isolates positive for Plasmodium falciparum mono infections were further genotyped for msp1 (MAD20, K1, and RO33), and msp2 allelic families (3D7 and FC27). Amplicons were resolved through capillary electrophoresis in the QIAxcel Advanced system.
Mono-infections were high and with 75% P. falciparum, 14% Plasmodium vivax and 9% P. falciparum/P. vivax co-infections, with less than 1% Plasmodium malariae identified. For msp1, MAD20 was the most prevalent (99%), followed by K1 (46%) allelic family, with no sample testing positive for RO33 (0%). For msp2, 3D7 allelic family was predominant (97%), followed by FC27 (10%). The multiplicity of infection of msp1 and msp2 was 2.6 and 1.1, respectively, and the mean overall multiplicity of infection was 3.7, with the total number of alleles ranging from 1 to 7.
Given the increasing importance of antimalarial drugs in the region, the genetic diversity of P. falciparum msp1 and msp2 should be regularly monitored with respect to treatment outcomes and/or efficacy studies in regions, where there are ongoing changes in the malaria epidemiology.
虽然世界卫生组织(WHO)东南亚区域的疟疾发病率位居世界第二,但越南的疟疾仅集中在少数几个省份,这些省份有记录表明抗疟药物的寄生虫清除出现延迟。本研究旨在使用分子工具了解寄生虫种群中疟原虫种类的分布和 msp1 和 msp2 的遗传多样性。
对 222 例来自无并发症疟疾个体的临床分离株进行嵌套实时 PCR 鉴定疟原虫种类。对 166 例经鉴定为恶性疟原虫单一感染的分离株进一步进行 msp1(MAD20、K1 和 RO33)和 msp2 等位基因家族(3D7 和 FC27)的基因分型。扩增子通过 QIAxcel 高级系统中的毛细管电泳进行解析。
单一感染率高,其中 75%为恶性疟原虫、14%为间日疟原虫和 9%为恶性疟原虫/间日疟原虫混合感染,不到 1%为恶性疟原虫。对于 msp1,MAD20 是最常见的(99%),其次是 K1 等位基因家族(46%),没有样本对 RO33 呈阳性(0%)。对于 msp2,3D7 等位基因家族占主导地位(97%),其次是 FC27(10%)。msp1 和 msp2 的感染多样性分别为 2.6 和 1.1,总体感染多样性平均值为 3.7,等位基因数量从 1 到 7 不等。
鉴于该区域抗疟药物的重要性不断增加,应定期监测恶性疟原虫 msp1 和 msp2 的遗传多样性,以便在疟疾流行病学不断变化的地区开展治疗结果和/或疗效研究。